摘要
Osteosarcoma (OS) is the most common primary bone malignancy in children and adolescents which has the survival rate of 20% in its advanced stages. Osteosarcomas are mostly resistance to our common treatments. DNA damage response (DDR) is a specialized multistep process containing abundant proteins which are necessary for the survival of any cell and organism. DDR machinery detects a diversity of DNA lesions and inhibits the cell cycle progression if these lesions are not repairable. DDR is involved in aging, age-related diseases, and cancer. In recent years, DDR inhibitors have gained the attention of researches due to their potentials in offering novel therapeutic targets and improving the response of many cancers to either chemo- or radio-therapy. In this regard, we tried to gather a great body of evidence about the role of DDR ingredients in osteosarcoma’s initiation/progression, prognosis, and treatment.
学科与关键词
- Recent advances in DDR (DNA damage response) inhibitors for cancer therapyCheng, Binbin; Pan, Wei; Xing, Yi; Xiao, Yao; Chen, Jianjun*; Xu, Zheng*European Journal of Medicinal Chemistry, 2022, 230: 114109.被引 37
- The DNA Damage Response: Making It Safe to Play with KnivesCiccia A; Elledge S J*2010.被引 2895
- Impairment of DNA damage response and cancerRancoule Chloe; Vallard Alexis; Guy Jean Baptiste; Espenel Sophie; Sauvaigo Sylvie; Rodriguez Lafrasse Claire; Magne NicolasBulletin du Cancer, 2017, 104(11): 962-970.
